Les actions de Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) were trading higher on Thursday after the company announced that it had completed the acquisition of the NexGenAI Affiliates Network platform and the launch of Coeptis Technologies.
This new division is designed to diversify the company’s growth prospects, specifically in highly regulated sectors such as biotechnology, pharmaceuticals and multi-level marketing.
The NexGenAI Affiliates Network platform, developed by NexGenAI Solutions Group, is an AI-powered marketing software and robotic process automation (RPA) solution.
This tool helps marketers process large volumes of data, optimize campaigns, improve customer engagement and streamline operations – key success factors in the competitive and regulated industries served by Coeptis.
Also Read: SEALSQ Launches SEALQUANTUM.com Lab to Help Businesses Move to Quantum Encryption
Coeptis President and CEO Dave Mehalick emphasized that the integration of these AI-powered tools will be crucial to optimizing marketing strategies and achieving measurable results in industries where competition and regulatory challenges are intense.
Anshuman Dash, senior advisor behind the NexGenAI platform, highlighted that this acquisition aligns with Coeptis’ mission to revolutionize marketing and operational efficiency in the biotechnology sector.
By leveraging advanced AI and RPA technologies, Coeptis aims to enhance its service offerings and provide innovative solutions to address marketing challenges in the biotechnology, pharmaceutical and multi-level marketing industries. , setting the stage for future growth.
Price movement: At last check on Thursday, COEP stock was up 45.8% to $0.2070.
Related reading:
Photo via Shutterstock.
